Three Growth Companies On Chinese Exchange With Insider Ownership And Earnings Growth Of At Least 22 percent - Simply Wall St
| 688166 Stock | 30.14 1.06 3.40% |
About 62% of BrightGene Bio's investor base is looking to short. The analysis of the overall investor sentiment regarding BrightGene Bio Medical suggests that many traders are alarmed. The current market sentiment, together with BrightGene Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use BrightGene Bio Medical stock news signals to limit their universe of possible portfolio assets.
BrightGene |
Three Growth Companies On Chinese Exchange With Insider Ownership And Earnings Growth Of At Least 22 Simply Wall St
Read at news.google.com
 |
BrightGene Bio Fundamental Analysis
We analyze BrightGene Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BrightGene Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BrightGene Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
BrightGene Bio is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Peers
Trending Equities
Complementary Tools for BrightGene Stock analysis
When running BrightGene Bio's price analysis, check to measure BrightGene Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrightGene Bio is operating at the current time. Most of BrightGene Bio's value examination focuses on studying past and present price action to predict the probability of BrightGene Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrightGene Bio's price. Additionally, you may evaluate how the addition of BrightGene Bio to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |